Literature DB >> 24286947

Advanced glycation endproducts in diabetes and diabetic complications.

Helen Vlassara1, Gary E Striker.   

Abstract

This review presents insights from studies of advanced glycation end products (AGEs) in humans and mice. Although the emphasis is on the effects of exogenous AGEs and the suppression of specific host defense mechanisms, AGEs are also formed intracellularly, where they may contribute to several normal intracellular functions. It is only when the overall levels of AGEs in the extracellular and the intracellular spaces exceeds the ability of the native antioxidant (and AGE) defenses that they pose a problem.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycation endproduct; Diabetes; Insulin resistance; Metabolism

Mesh：

Substances：

Year:  2013        PMID： 24286947     DOI： 10.1016/j.ecl.2013.07.005

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  41 in total

1.  Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise.

Authors:  Y Li; T Zhang; Q Huang; Y Sun; X Chang; H Zhang; Y Zhu; X Han
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

2.  Pharmacological treatment of diabetic peripheral neuropathy.

Authors:  Kenneth Cohen; Nataliya Shinkazh; Jerry Frank; Igor Israel; Chris Fellner
Journal:  P T       Date:  2015-06

3.  Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration.

Authors:  Sheldon Rowan; Shuhong Jiang; Tal Korem; Jedrzej Szymanski; Min-Lee Chang; Jason Szelog; Christa Cassalman; Kalavathi Dasuri; Christina McGuire; Ryoji Nagai; Xue-Liang Du; Michael Brownlee; Naila Rabbani; Paul J Thornalley; James D Baleja; Amy A Deik; Kerry A Pierce; Justin M Scott; Clary B Clish; Donald E Smith; Adina Weinberger; Tali Avnit-Sagi; Maya Lotan-Pompan; Eran Segal; Allen Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

4.  Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.

Authors:  V C Luft; B B Duncan; M I Schmidt; L E Chambless; J S Pankow; R C Hoogeveen; D J Couper; G Heiss
Journal:  Diabet Med       Date:  2015-10-06       Impact factor: 4.359

Review 5.  Humans as cucinivores: comparisons with other species.

Authors:  John B Furness; David M Bravo
Journal:  J Comp Physiol B       Date:  2015-06-30       Impact factor: 2.200

6.  Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.

Authors:  Elena M Yubero-Serrano; Mark Woodward; Leonid Poretsky; Helen Vlassara; Gary E Striker
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

Review 7.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

8.  Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice.

Authors:  Cheng-Chin Hsu; Hui-Ting Yang; Jing-Jing Ho; Mei-Chin Yin; Jen-Ying Hsu
Journal:  Eur J Nutr       Date:  2015-07-22       Impact factor: 5.614

Review 9.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

10.  A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress.

Authors:  Ethan J Anderson; Giulio Vistoli; Lalage A Katunga; Katsuhiko Funai; Luca Regazzoni; T Blake Monroe; Ettore Gilardoni; Luca Cannizzaro; Mara Colzani; Danilo De Maddis; Giuseppe Rossoni; Renato Canevotti; Stefania Gagliardi; Marina Carini; Giancarlo Aldini
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.